Genotyping of the MTL loci and susceptibility to two antifungal agents of Candida glabrata clinical isolates

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 5, 2009, Pages 775-782

  Lavaniegos Sobrino, María Teresa ^a   Ramírez Zavaleta, Candy Y ^a   de León, Alfredo Ponce ^b   Sifuentes Osornio, José ^b   Valle, Miriam Bobadilla Del ^b   Rangel Cordero, Andrea ^b   Peñas, Alejandro de Las ^a   Castaño, Irene ^a  

^a INSTITUTO POTOSINO DE INVESTIGACIÓN CIENTÍFICA Y TECNOLÓGICA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

5 fluorocytosine; Candida glabrata; Clinical isolate; Fluconazole; Mating type loci; MTL

Indexed keywords

CANDIDA; CANDIDA GLABRATA;

EID: 70349661732     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000500019     Document Type: Article

References (29)

1. Ausubel F, Brent R, Kingston RE, Moore dD, Seidman JG, Smith JA, Struhl K 2001. Current protocols in molecular biology, Wiley & Sons, New York, 670 pp.
2. Bahn YS, Xue CY, Idnurm A, Rutherford JC, Heitman J, Cardenas ME 2007. Sensing the environment: lessons from fungi. Nat Rev Microbiol 5: 57-69.
3. Brisse S, Pannier C, Angoulvant A, de Meeus T, Diancourt L, Faure O, Muller H, Peman J, Viviani MA, Grillot R, Dujon B, Fairhead C, Hennequin C 2009. Uneven distribution of mating types among genotypes of Candida glabrata isolates from clinical samples. Eukaryot Cell 8: 287-295.
4. Byrne KP, Wolfe KH 2005. The yeast gene order browser: combining curated homology and syntenic context reveals gene fate in polyploid species. Genome Res 15: 1456-1461.
5. Cormack BP, Falkow S 1999. Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata. Genetics 151: 979-987.
6. Dodgson AR, Pujol C, Pfaller MA, Denning DW, Soll DR 2005. Evidence for recombination in Candida glabrata. Fungal Genet Biol 42: 233-243.
7. Genolevures - French Bioinformatics Platforms Networks [Bordeaux Bioinformatics Center] 2004. Available from: http://www.genolevures.org/elt/CAGL/CAGL.
8. Gonzalez GM, Elizondo M, Ayala J 2008. Trends in species distribution and susceptibility to seven antifungal agents of bloodstream isolates of Candida in Monterrey, Mexico. Results of a 3-Year (2004-2007). Surveillance Study. J Clin Microbiol 46: 2902-2905.
9. Heitman J 2006. Sexual reproduction and the evolution of microbial pathogens. Curr Biol 16: R711-R725.
10. Herskowitz J, Rine J, Strathern J 1992. Mating type determination and mating-type interconversion in Saccharomyces cerevisiae, Cold Spring Harbor Laboratory Press, New York, 810 pp.
11. Hull CM, Johnson AD 1999. Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science 285: 1271-1275.
12. Hull CM, Raisner RM, Johnson AD 2000. Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host. Science 289: 307-310.
13. Jarvis WR 1995. Epidemiology of nosocomial fungal infections with emphasis on Candida species. Clin Infect Dis 20: 1526-1530.
14. Johnson A 2003. The biology of mating in Candida albicans. Nat Rev Microbiol 1: 106-116.
15. Kaur R, Castano I, Cormack BP 2004. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria. Antimicrob Agents Chemother 48: 1600-1613.
16. Magee BB, Magee PT 2000. Induction of mating in Candida albicans by construction of MTLa and MTLalpha strains. Science 289: 310-313.
17. Manzano-Gayosso P, Mendez-Tovar LJ, Hernandez-Hernandez F, Lopez-Martinez R 2008. Antifungal resistance: an emerging problem in Mexico. Gac Med Mex 144: 23-26.
18. Messer SA, Jones RN, Fritsche TR 2006. International surveillance of Candida spp. and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2003). J Clin Microbiol 44: 1782-1787.
19. Muller H, Hennequin C, Gallaud J, Dujon B, Fairhead C 2008. The asexual yeast Candida glabrata maintains distinct a and alpha haploid mating types. Eukaryot Cell 7: 848-858.
20. Nguyen MH, Peacock JE Jr, Morris AJ, Tanner DC, Nguyen ML, Snydman DR, Wagener MM, Rinaldi MG, Yu VL 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 100: 617-623.
21. Pfaller MA, Diekema DJ 2004. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 10 (Suppl. 1): 11-23.
22. Pfaller MA, Diekema DJ 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
23. Richardson MD 2005. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56 (Suppl. 1): i5-i11.
24. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 43: 2155-2162.
25. Rogers PD, Barker KS 2003. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrobial Agents Chemother 47: 1220-1227.
26. Sherman F, Fink GR, Hicks JB 1986. Methods in yeast genetics, Cold Spring Harbor Laboratory Press, New York, 186 pp.
27. Srikantha T, Lachke SA, Soll DR 2003. Three mating type-like loci in Candida glabrata. Eukaryot Cell 2: 328-340.
28. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gayne RP 2002. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35: 627-630.
29. Wong S, Fares MA, Zimmermann W, Butler G, Wolfe KH 2003. Evidence from comparative genomics for a complete sexual cycle in the 'asexual' pathogenic yeast Candida glabrata. Genome Biol 4: R10.